Y
Youzhiyou Biopharmaceutical
A biotechnology company that develops anti-tumor bispecific antibodies
About Youzhiyou Biopharmaceutical
YZY Biopharma is a biotechnology company specializing in the development of bispecific antibodies aimed at enhancing T cell infiltration and antitumor activity, particularly for triple-negative breast cancer. Operating in the biopharmaceutical sector, YZY Biopharma serves clients in the healthcare and medical research industries, focusing on innovative immunotherapy solutions. The company's business model revolves around the research, development, and commercialization of advanced therapeutic antibodies. Revenue is generated through partnerships, licensing agreements, and direct sales of their proprietary biopharmaceutical products. YZY Biopharma's market includes both China and the United States, where it leverages cutting-edge technology and scientific research to address unmet medical needs in oncology and immunotherapy.
Source: Dealroom company dataAt a glance
- Founded
- 2010
- Headquarters
- Wuhan, China
- Sector
- Biotech & Life Sciences
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later3 investors entered at this stage
- HIHubei Science and Technology Investment
- WHWuhan Hi-Tech
- WGWuhan Optics Valley Financial Holding Group
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Youzhiyou Biopharmaceutical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Youzhiyou Biopharmaceutical on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.